Calycia Bioscience Wins People’s Choice Award at Altitude Lab Demo Day 2026
April 23, 2026
Calycia Bioscience was awarded the People’s Choice Award at the 2026 Altitude Labs Demo Day. CaLycia is developing engineered macrophage therapies that hone in on solid tumors and alleviate immune suppression, unlocking a broader immune response against some of the hardest targets in oncology. BioUtah congratulates Daniel Greiner and the Calycia Bioscience team!
Recent News
- Ardelyx Presents Real-World Data at ACG 2026 Showing Reduced Healthcare Resource Utilization Following IBSRELA Initiation in Adults with IBS-C
- Co-Diagnostics Announces First Full Vector Smart® Laboratory Installation for Native American Tribe
- Co-Diagnostics to Showcase Co-Dx PCR Platform* and MTB Test at WHX Labs Johannesburg, Highlight Ebola Assay Development
- Co-Diagnostics Highlights Vector Smart® Momentum Following New Federal Initiative on Vector-Borne Disease
- BlueWind Medical Announces Humana Coverage of Revi® for Urgency Urinary Incontinence, Expanding Access to Millions of Patients
- Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
